These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 38059359)
1. Endothelin System in Hypertension and Chronic Kidney Disease. Schiffrin EL; Pollock DM Hypertension; 2024 Apr; 81(4):691-701. PubMed ID: 38059359 [TBL] [Abstract][Full Text] [Related]
2. Potential Role of Endothelin in Early Vascular Aging. Trindade M; Oigman W; Fritsch Neves M Curr Hypertens Rev; 2017; 13(1):33-40. PubMed ID: 28413991 [TBL] [Abstract][Full Text] [Related]
3. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction. Holm P Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559 [TBL] [Abstract][Full Text] [Related]
4. Possible therapeutic role of endothelin antagonists in cardiovascular disease. Ram CV Am J Ther; 2003; 10(6):396-400. PubMed ID: 14624276 [TBL] [Abstract][Full Text] [Related]
5. [New expansion of endothelin research: perspectives for clinical application of endothelin-receptor antagonists]. Goto K; Miyauchi T Nihon Yakurigaku Zasshi; 2003 Feb; 121(2):91-101. PubMed ID: 12616854 [TBL] [Abstract][Full Text] [Related]
6. The endothelin system as target for therapeutic interventions in cardiovascular and renal disease. Eroglu E; Kocyigit I; Lindholm B Clin Chim Acta; 2020 Jul; 506():92-106. PubMed ID: 32151622 [TBL] [Abstract][Full Text] [Related]
7. Endothelin antagonism and its role in the treatment of hypertension. Moorhouse RC; Webb DJ; Kluth DC; Dhaun N Curr Hypertens Rep; 2013 Oct; 15(5):489-96. PubMed ID: 23912930 [TBL] [Abstract][Full Text] [Related]
8. The endothelin system in pulmonary arterial hypertension. Galié N; Manes A; Branzi A Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders. Spieker LE; Noll G; Lüscher TF Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028 [TBL] [Abstract][Full Text] [Related]
14. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade. Jasmin JF; Cernacek P; Dupuis J Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096 [TBL] [Abstract][Full Text] [Related]
15. Endothelin receptor antagonists: an overview of their synthesis and structure-activity relationship. Iqbal J; Sanghia R; Das SK Mini Rev Med Chem; 2005 Apr; 5(4):381-408. PubMed ID: 15853628 [TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders. Goddard J; Webb DJ Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541 [TBL] [Abstract][Full Text] [Related]
17. Endothelin: 30 Years From Discovery to Therapy. Barton M; Yanagisawa M Hypertension; 2019 Dec; 74(6):1232-1265. PubMed ID: 31679425 [TBL] [Abstract][Full Text] [Related]
18. Putative mediator role of endothelin-1 in asthma and other lung diseases. Hay DW Clin Exp Pharmacol Physiol; 1999 Feb; 26(2):168-71. PubMed ID: 10065341 [TBL] [Abstract][Full Text] [Related]
19. Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors. Filep JG; Fournier A; Földes-Filep E Br J Pharmacol; 1995 May; 115(2):227-36. PubMed ID: 7670725 [TBL] [Abstract][Full Text] [Related]
20. Endothelin as a regulator of cardiovascular function in health and disease. Haynes WG; Webb DJ J Hypertens; 1998 Aug; 16(8):1081-98. PubMed ID: 9794709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]